publication date: Jun 27, 2012
|
author/source: Phoenix MarCom Ltd
NoemaLife, Europe's leading provider
of clinical and hospital software solutions, will exhibit the company's HALIA
middleware for clinical chemistry, microbiology and molecular biology labs at
this year's AACC (American Association of Clinical Chemists) Annual Meeting
(15-19 July 2012, Los Angeles, CA).
HALIA middleware interface provides
a complete web-based lab computerisation system that allows central management
and connection of all analysers through a single interface on any workstation.
Using a user-configurable, rule-based engine, HALIA delivers all-round control
over laboratory workflow and sample processing for significant improvements in
laboratory efficiency, compliance and quality control.
Auto-verification, sample routing
and real-time clinical data capture and management, enable improved quality
control. By supporting open automation systems, and addressing issues such as
regulatory compliance, workforce reductions and enhanced quality control, HALIA
meets the complex automation and data management challenges currently facing
laboratory managers.
Growing levels of Point of Care
Testing are reflected in HALIA's POCT Data Manager function. This gives lab
managers a real-time overview of all the data relating to multiple blood gas
analysers or other devices, including instrument maintenance schedules and QC
alerts.
Importantly, HALIA also provides
detailed real-time data on total turnaround time (TAT) - a key performance
indicator in laboratories striving to increase throughput. Addressing the
situation where works stops if a LIS/LIMS system goes down, HALIA's LIS/LIMS
backup module allows manual input of sample information so that analysis can
continue. Manual samples are then matched to LIS/LIMS data once the connection
is restored.
Andrea Chiapponi, Managing Director
of NoemaLife S.p.A., commented, ‘In addition to laboratories looking for open
middleware which is vendor independent, HALIA will be of interest to IVD device
vendors wanting to create turnkey solutions which include maximum LIS/LIMS
connectivity. HALIA's vendor-independence also enables merging of laboratories
and even hospitals with different LIS/LIMS solutions into a seamless wide area
network. For example, HALIA can manage re-tests on different analysers deployed
in separate labs and co-ordinate specimen storage information relating to
multiple locations.'
HALIA takes middleware to new levels
by providing complete flexibility with simplified integration for all
healthcare situations.
Foir more information visit
www.noemalife.com
About NoemaLife
NoemaLife is a leading provider of clinical and hospital IT Software
Solutions, dedicated to the enhancement of workflow automation, cost savings
and quality of care at every level of the healthcare delivery process. It has
been listed on the Italian Stock Exchange (MTA) since 2006 (NOE-ISIN
IT0004014533).
NoemaLife, which employs a staff of 700 qualified professionals
worldwide, has a direct market presence in Italy, Germany, France, United
Kingdom, Belgium, Japan, Argentina, Chile and the United Arab Emirates. It also
operates in Latin America, Northern Europe and Australia through a distribution
network. Thanks to its acquisition in 2011 of a majority stake in the French
group
Medasys,
NoemaLife
consolidated its role as leading European vendor of IT solutions for clinical
processes.
The NoemaLife Group closed 2011 with
consolidated sales of 48.5 million euros (+13% on 2010).